Immunocytochemistry Test of Protein BRAF Expression for Diagnosis of Well Differentiated Thyroid Carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Immunocytochemistry Test of Protein BRAF Expression for Diagnosis of Well Differentiated Thyroid Carcinoma ; volume:11 ; number:3 ; year:2018 ; pages:843-849
Case reports in oncology ; 11, Heft 3 (2018), 843-849
- Creator
-
Sudarsa, I. Wayan
Pualillin, Elvis Deddy Kurniawan
Adiputra, Putu Anda Tusta
Manuaba, Ida Bagus Tjakra Wibawa
- DOI
-
10.1159/000495029
- URN
-
urn:nbn:de:101:1-2019010923222962918461
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sudarsa, I. Wayan
- Pualillin, Elvis Deddy Kurniawan
- Adiputra, Putu Anda Tusta
- Manuaba, Ida Bagus Tjakra Wibawa
Other Objects (12)
Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer
Well-differentiated (Marschalko-type) plasmacytoma resembling thyroid follicular structures
Establishing a Cutoff Serum Thyroglobulin Value for the Diagnosis and Management of Well-Differentiated Thyroid Cancer
Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers
Frozen section analysis and sentinel lymph node biopsy in well differentiated thyroid cancer
Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material
Preradioactive Iodine Thyroglobulin Levels as Predictors of Metastasis in Well-Differentiated Thyroid Carcinoma Patients
Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors
Unusual Presentation of Differentiated Thyroid Cancer Metastasis
Poorly differentiated thyroid carcinoma : An underdiagnosed entity
Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?
Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells
Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer
Well-differentiated (Marschalko-type) plasmacytoma resembling thyroid follicular structures
Establishing a Cutoff Serum Thyroglobulin Value for the Diagnosis and Management of Well-Differentiated Thyroid Cancer
Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers
Frozen section analysis and sentinel lymph node biopsy in well differentiated thyroid cancer
Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material
Preradioactive Iodine Thyroglobulin Levels as Predictors of Metastasis in Well-Differentiated Thyroid Carcinoma Patients
Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors
Unusual Presentation of Differentiated Thyroid Cancer Metastasis
Poorly differentiated thyroid carcinoma : An underdiagnosed entity
Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?
Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells
Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer
Well-differentiated (Marschalko-type) plasmacytoma resembling thyroid follicular structures
Establishing a Cutoff Serum Thyroglobulin Value for the Diagnosis and Management of Well-Differentiated Thyroid Cancer
Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers
Frozen section analysis and sentinel lymph node biopsy in well differentiated thyroid cancer
Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material
Preradioactive Iodine Thyroglobulin Levels as Predictors of Metastasis in Well-Differentiated Thyroid Carcinoma Patients
Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors
Unusual Presentation of Differentiated Thyroid Cancer Metastasis
Poorly differentiated thyroid carcinoma : An underdiagnosed entity
Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?